Skip to main content
. 2022 Apr 1;17(17):e1417–e1424. doi: 10.4244/EIJ-D-21-00464

Table 2. Procedural data and complications.

Without* LVOT calcification (n=358) With** LVOT calcification (n=358) p-value
Procedural characteristics
Fluoroscopy time, min 17.2 (13.1, 24.6) 19.5 (14.5, 26.8) 0.04
Procedure time, min 75.0 (60.0, 95.0) 80.0 (65.0, 105.6) 0.01
Contrast, mL 178.0 (135.0, 224.1) 179.0 (139.4, 225.6) 0.43
Type of valve Balloon-expandable 192 (53.6) 112 (31.3) <0.001
Self-expanding# 148 (41.3) 187 (52.2) 0.004
Mechanically expandable 18 (5.0) 59 (16.5) <0.001
Predilation 268 (75.1) 276 (77.5) 0.49
Ratio balloon pre/annulus size, % –7.5±6.2 –8.8±5.2 0.01
Post-dilation 121 (34.0) 127 (35.8) 0.67
Ratio balloon post/annulus size, % –0.0±5.1 –0.7±5.0 0.32
Oversizing, area % 13.7 (5.7, 22.4) 10.9 (3.7, 23.0) 0.12
CEP, % 49 (13.7) 75 (21.1) 0.01
Procedural outcome and complications
Technical success§ 315 (89.0) 299 (84.5) 0.10
Valve-dislocation/malposition 6 (1.7) 10 (2.8) 0.44
Bail-out valve-in-valve 5 (1.4) 8 (2.3) 0.57
Aortic root rupture 0 (0) 2 (0.6) 0.48
Cardiac tamponade 1 (0.3) 1 (0.3) 1.00
Coronary artery obstruction 2 (0.6) 1 (0.3) 1.00
*Without ≤10 mm3 LVOT calcium volume. **With >10 mm3 LVOT calcium volume. §At exit from procedure room according to VARC-3 criteria. SAPIEN 3; #Evolut R, Portico, ACURATE neo, ALLEGRA; ◊ LOTUS Edge. Values are mean±SD, n (%) unless otherwise indicated or median (interquartile range). CEP: cerebral embolic protection devices; LVOT: left ventricular outflow tract